Cargando…
Epstein Barr virus DNA analysis in blood predicts disease progression in a rare case of plasmablastic lymphoma with effusion
BACKGROUND: In HIV-1-infected patients a long lasting CD4+ cell decline influences the host-EBV balance and thereby increases the risk for EBV related malignancies. In spite of a world-wide access to combination antiretroviral therapy (cART) there are still a considerable number of HIV-1-infected pa...
Autores principales: | Friis, Anna, Åkerlund, Börje, Christensson, Birger, Gyllensten, Katarina, Aleman, Anna, Zou, Jie-Zhi, Ernberg, Ingemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726497/ https://www.ncbi.nlm.nih.gov/pubmed/23880011 http://dx.doi.org/10.1186/1750-9378-8-28 |
Ejemplares similares
-
The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients
por: Friis, Anna M. C., et al.
Publicado: (2010) -
Fulminant anaplastic large cell lymphoma (ALCL) concomitant with primary cytomegalovirus (CMV) infection, and human herpes virus 8 (HHV-8) infection together with Epstein-Barr-virus (EBV) reactivation in a patient with asymptomatic HIV-infection
por: Grützmeier, Sven, et al.
Publicado: (2016) -
Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System
por: Andersen, Oluf, et al.
Publicado: (2023) -
Epstein-Barr virus latency switch in human B-cells: a physico-chemical model
por: Werner, Maria, et al.
Publicado: (2007) -
Epstein–Barr Virus Primary Infection Complicated by Hemophagocytic Lymphohistiocytosis and Plasmablastic Lymphoma in a HIV-Negative Patient
por: Chen, Nan, et al.
Publicado: (2019)